A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer
D
D
Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.
Hölscher
Arnulf H
AH
DeMeester
S
S
DeMeester
T
T
Salo
J
J
Peters
J
J
Lerut
T
T
Swisher
S G
SG
Schröder
W
W
Bollschweiler
E
E
Hofstetter
W
W
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016629:Esophagectomy; D005060:Europe; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D016019:Survival Analysis; D013908:Thoracotomy; D016896:Treatment Outcome; D014481:United States